These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12474459)

  • 21. [Laser technologies in treatment of patients with pulmonary tuberculosis with concurrent abnormality].
    Maliev BM; Egorova IL; Sorokina IA; Tarnueva OK; Ermakova GI
    Probl Tuberk; 1998; (3):38-41. PubMed ID: 9691688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the efficiency of a hospital stage of treatment in delivering antituberculous care to mental patients with active pulmonary tuberculosis].
    Borzenko AS; Zubova EIu; Iaitskiĭ IuA
    Probl Tuberk Bolezn Legk; 2007; (6):37-40. PubMed ID: 17672060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The current aspects of the recurrence of tuberculosis of the respiratory organs in adults].
    Gavrilenko VS; Khruleva TS
    Probl Tuberk; 1996; (4):2-4. PubMed ID: 9026797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of infrared laser irradiation on immunologic reactivity of patients with infiltrative pulmonary tuberculosis].
    Tuiakov MI; Budchanov IuI; Zhangireev AA; Niiatova AA
    Probl Tuberk; 1993; (2):44-6. PubMed ID: 7984570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enhancing the efficiency of treatment in patients with multidrug resistant pulmonary tuberculosis by a combination of surgery and adequate chemotherapy].
    Erimbetov KD
    Probl Tuberk Bolezn Legk; 2003; (4):39-41. PubMed ID: 12774419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reserves for enhancing the efficiency of treatment for pulmonary tuberculosis in adolescents].
    Guseĭnov GK; Pakhieva KhIu; Balashova NA
    Probl Tuberk Bolezn Legk; 2006; (1):16-9. PubMed ID: 16512179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Risk factors of pulmonary tuberculosis in children with chronic nonspecific lung diseases].
    Mokhnachevskaia AI; Aksenova VA
    Probl Tuberk Bolezn Legk; 2006; (1):6-9. PubMed ID: 16512176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methodology for the assessment of epidemiological indices of pulmonary tuberculosis and the efficiency of tuberculosis control measures].
    Son IM; Litvinov VI; Starodubov VI; Sel'tsovskiĭ PP
    Probl Tuberk; 2002; (4):55-63. PubMed ID: 12125258
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Magnetic laser therapy in combination with lymphotropic drugs administration in treating teenagers with common forms of tuberculosis].
    Ovsiankina ES; Dobkin VG; Kobulashvili MG; Rusakova LI; Gubkina MF
    Probl Tuberk; 2000; (2):18-21. PubMed ID: 10838901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary drug resistance of Mycobacterium tuberculosis in adolescents with tuberculosis: the specific features of its clinical course, the efficiency of treatment].
    Firsova VA; Poluektova FG; Ryzhova AP
    Probl Tuberk Bolezn Legk; 2008; (5):17-20. PubMed ID: 18711813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cytogenic status of peripheral lymphocytes in pulmonary tuberculosis before and during chemotherapy].
    Novitskiĭ VV; Strelis AK; Urazova OI; Luk'ianova TA; Riabova EA; Esimova IE; Voronkova OV; Sinitsyna VA; Filiniuk OV; Zemlianaia NA
    Probl Tuberk Bolezn Legk; 2005; (5):43-6. PubMed ID: 15988978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficiency of plasmol in the complex treatment of patients with pulmonary tuberculosis].
    Gorgol VI
    Vrach Delo; 1972 Mar; 3():91-4. PubMed ID: 5046713
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis].
    Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy-induced lung functional changes in patients with destructive pulmonary tuberculosis].
    Nefedov VB; Smirnova DG
    Probl Tuberk; 1996; (6):60-3. PubMed ID: 9019776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI
    Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Laser therapy in the complex treatment of prostatic tuberculosis at the sanatorium stage of rehabilitation].
    Shakirov RG; Pavlov VN; Iagafarova RK
    Probl Tuberk Bolezn Legk; 2008; (4):35-8. PubMed ID: 18507146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of glucocorticosteroid hormones on T lymphocytes in patients with pulmonary tuberculosis].
    Basov PV
    Probl Tuberk; 1989; (4):30-3. PubMed ID: 2786631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychoemotional changes in patients with pulmonary tuberculosis during therapy using psychological and neuropsychological methods].
    Strel'tsov VV; Siresina NN; Zolotova NV; Baranova GV; Stolbun IuV; Dolgova IuV; Pankova LI; Erokhin VV; Ergeshov AE; Chernykh NA; Kuz'min AV; Rodina OV; Sel'tsovskiĭ PP
    Probl Tuberk Bolezn Legk; 2009; (4):31-7. PubMed ID: 19514451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.